Moderna Inc. buy Royal Bank of Canada
Start price
23.02.24
/
50%
€89.00
Target price
23.02.25
€115.45
Performance (%)
25.15%
Price
12.07.24
€111.38
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada currently has a performance of 25.15%. This prediction currently runs until 23.02.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Moderna Inc. | 2.071% | 2.071% |
iShares Core DAX® | 1.454% | 0.904% |
iShares Nasdaq 100 | -0.913% | 3.463% |
iShares Nikkei 225® | 2.355% | 3.830% |
iShares S&P 500 | 0.283% | 2.639% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Moderna Inc. diskutieren
Moderna, Inc. (NASDAQ: MRNA) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $125.00 price target on the stock.
Ratings data for MRNA provided by MarketBeat